April 22, 2013
Genital wart prevalence declined more than 90% among adolescent and teen girls in the four to five years after the HPV vaccine became available in Australia.
March 20, 2013
More than 40% of parents surveyed in 2010 reported they did not intend to vaccinate their adolescent female children with the HPV vaccine.
January 08, 2013
Despite reductions in overall cancer mortality, the burden of some HPV-associated cancers continues to rise.
October 15, 2012
Pregnancy rates, testing for or diagnosis of sexually transmitted infections, or receipt of contraceptive counseling did not differ among adolescent girls who received HPV vaccine at age 11 to 12 and those who did not.
October 01, 2012
Dizziness, photophobia, nausea and an unsteady gait develop following a routine annual check up.
July 31, 2012
HPV DNA testing at baseline predicted progression to cervical intraepithelial neoplasia grade 3 at 18-year follow-up more accurately than Pap smear.
April 20, 2012
Additional surveillance and methodology are needed to assess the impact of HPV vaccines on disease incidence going forward.
Encouraging patients of both sexes to receive the HPV vaccine will help achieve higher herd immunity rates and offer greater protection.
February 02, 2012
Three childhood vaccine schedules and accompanying footnotes offer new clarifications and guidance.
January 26, 2012
Higher prevalence of oral HPV in men than women, and peaks at ages 30 to 34 years and 60 to 64 years correlate with trends in oropharyngeal squamous-cell carcinoma incidence.
December 26, 2011
The CDC's Advisory Committee on Immunization Practices issued HPV and hepatitis B vaccine recommendations based on efficacy and safety data in specific patient populations.
Increasing HPV vaccine uptake among preadolescent girls is more effective in reducing HPV infection than including boys in existing vaccination programs would be, researchers from the Netherlands say.
December 16, 2011
DNA testing for human papillomavirus (HPV) picks up precancerous lesions earlier and prevents more cervical cancer than standard cytology screening alone.
The U.S. Preventive Services Task Force says screening too frequently for cervical cancer may cause unnecessary anxiety, increases in invasive diagnostic procedures and over treatment with procedures that pose potentially more harm than benefit.
September 26, 2011
Common reasons that parents give when declining human papillomavirus vaccine for their children are, "My teen is not sexually active," or "Maybe we'll wait until he/she is a bit older." This thinking negates the vaccine's preventive purpose.
DNA-based testing for HPV-16 and HPV-18 detects cervical cancer better than liquid-based cytology, data from the ATHENA trial indicate.
Which type of human papillomavirus (HPV) is associated with nonmucosal, condyloma acuminatum-appearing warts found under the pannus in intertriginous areas?
Clinician-patient education programs can help dispel human papillomavirus vaccine misconceptions and improve uptake rates, according to a researcher at the American Academy of Nurse Practitioners 26th Annual NP meeting.
